PL2654784T3 - Stabilne immunogenne kompozycje antygenów staphylococcus aureus - Google Patents

Stabilne immunogenne kompozycje antygenów staphylococcus aureus

Info

Publication number
PL2654784T3
PL2654784T3 PL11804822T PL11804822T PL2654784T3 PL 2654784 T3 PL2654784 T3 PL 2654784T3 PL 11804822 T PL11804822 T PL 11804822T PL 11804822 T PL11804822 T PL 11804822T PL 2654784 T3 PL2654784 T3 PL 2654784T3
Authority
PL
Poland
Prior art keywords
staphylococcus aureus
immunogenic compositions
aureus antigens
stable immunogenic
stable
Prior art date
Application number
PL11804822T
Other languages
English (en)
Inventor
Lakshmi Khandke
Akihisa Nonoyama
Tamara Shafer Hodge
Sandeep Nema
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Publication of PL2654784T3 publication Critical patent/PL2654784T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/085—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6037—Bacterial toxins, e.g. diphteria toxoid [DT], tetanus toxoid [TT]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
PL11804822T 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus PL2654784T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201061426476P 2010-12-22 2010-12-22

Publications (1)

Publication Number Publication Date
PL2654784T3 true PL2654784T3 (pl) 2017-08-31

Family

ID=45444677

Family Applications (2)

Application Number Title Priority Date Filing Date
PL16193095T PL3150222T3 (pl) 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus
PL11804822T PL2654784T3 (pl) 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL16193095T PL3150222T3 (pl) 2010-12-22 2011-12-21 Stabilne immunogenne kompozycje antygenów staphylococcus aureus

Country Status (18)

Country Link
US (1) US20130259896A1 (pl)
EP (2) EP3150222B1 (pl)
JP (1) JP6097478B2 (pl)
KR (2) KR101808398B1 (pl)
CN (1) CN103826656B (pl)
AU (1) AU2011346535B2 (pl)
BR (1) BR112013016153A2 (pl)
CA (1) CA2819120C (pl)
DK (2) DK2654784T3 (pl)
ES (2) ES2614815T3 (pl)
HU (2) HUE047263T2 (pl)
IL (1) IL226793B (pl)
MX (1) MX350170B (pl)
PL (2) PL3150222T3 (pl)
PT (2) PT2654784T (pl)
RU (1) RU2570730C2 (pl)
SI (2) SI2654784T1 (pl)
WO (1) WO2012085872A2 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008513406A (ja) 2004-09-22 2008-05-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
EP3461496B1 (en) 2009-06-22 2023-08-23 Wyeth LLC Compositions and methods for preparing staphylococcus aureus serotype 5 and 8 capsular polysaccharide conjugate immunogenic compositions
JP5395264B2 (ja) 2009-06-22 2014-01-22 ワイス・エルエルシー 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）抗原の免疫原性組成物
ES2614807T3 (es) * 2010-06-04 2017-06-02 Wyeth Llc Formulaciones vacunales
CA2830415A1 (en) * 2011-03-16 2012-12-13 Regents Of The University Of Minnesota Compositions and methods for inducing immune responses against bacteria in the genus staphylococcus
GB201310008D0 (en) * 2013-06-05 2013-07-17 Glaxosmithkline Biolog Sa Immunogenic composition for use in therapy
CA2932225C (en) * 2013-12-04 2023-01-17 Glycovaxyn Ag Prevention of staphylococcus aureus infections by glycoprotein vaccines synthesized in escherichia coli
IL310015B1 (en) 2013-12-31 2025-10-01 Access To Advanced Health Inst Single vial formulation
JP6762877B2 (ja) * 2014-04-10 2020-09-30 アシット バイオテック エスエー 熱ショックタンパク質を本質的に含まない医薬製剤、医薬製剤を含むバイアル又は投与具、バイアル又は投与具を含むキット、並びにアレルギーの治療方法
WO2019036313A1 (en) * 2017-08-16 2019-02-21 Merck Sharp & Dohme Corp. CONJUGATED PNEUMOCOCCAL VACCINE FORMULATIONS
GB201802339D0 (en) 2018-02-13 2018-03-28 Glaxosmithkline Biologicals Sa Immunogenic composition
KR102646145B1 (ko) 2018-05-31 2024-03-11 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 모공 축소용 조성물
CN112261871B (zh) 2018-07-28 2022-05-17 韩国外泌体生技有限公司 用于使外排体冻干的方法
KR102163806B1 (ko) 2018-07-30 2020-10-07 주식회사 엑소코바이오 줄기세포 유래의 엑소좀을 유효성분으로 포함하는 피지분비 감소용 조성물
IL294461A (en) * 2020-01-13 2022-09-01 Aptevo Res & Development Llc Methods and compositions for preventing adsorption of therapeutic proteins to drug delivery system components

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902506A (en) 1983-07-05 1990-02-20 The University Of Rochester Immunogenic conjugates
US4673574A (en) 1981-08-31 1987-06-16 Anderson Porter W Immunogenic conjugates
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
SE8405493D0 (sv) 1984-11-01 1984-11-01 Bror Morein Immunogent komplex samt sett for framstellning derav och anvendning derav som immunstimulerande medel
US5078996A (en) 1985-08-16 1992-01-07 Immunex Corporation Activation of macrophage tumoricidal activity by granulocyte-macrophage colony stimulating factor
US5057540A (en) 1987-05-29 1991-10-15 Cambridge Biotech Corporation Saponin adjuvant
US4912094B1 (en) 1988-06-29 1994-02-15 Ribi Immunochem Research Inc. Modified lipopolysaccharides and process of preparation
CA2017507C (en) 1989-05-25 1996-11-12 Gary Van Nest Adjuvant formulation comprising a submicron oil droplet emulsion
IT1253009B (it) 1991-12-31 1995-07-10 Sclavo Ricerca S R L Mutanti immunogenici detossificati della tossina colerica e della tossina lt, loro preparazione ed uso per la preparazione di vaccini
US5571515A (en) 1994-04-18 1996-11-05 The Wistar Institute Of Anatomy & Biology Compositions and methods for use of IL-12 as an adjuvant
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6008341A (en) 1994-08-22 1999-12-28 The Provost, Fellows And Scholars Of The College Of The Holy And Undivided Trinity Of Queen Elizabeth Near Dublin S. aureus fibrinogen binding protein gene
BE1008978A5 (fr) 1994-12-27 1996-10-01 Solvay Adjuvants pour vaccins.
EP0857214A1 (en) 1995-10-16 1998-08-12 Smithkline Beecham Plc Novel saliva binding protein
GB9622159D0 (en) 1996-10-24 1996-12-18 Solvay Sociutu Anonyme Polyanionic polymers as adjuvants for mucosal immunization
GB9622660D0 (en) 1996-10-31 1997-01-08 Biocine Spa Immunogenic detoxified mutant toxin
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
EP2319931A1 (en) 1997-11-26 2011-05-11 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
US6680195B1 (en) 1997-11-26 2004-01-20 Inhibitex, Inc. Extracellular matrix-binding proteins from staphylococcus aureus
BR9913340A (pt) * 1998-08-31 2001-11-06 Inhibitex Inc Composição, vacina, e, processos de gerar uma resposta imune, e de inibir a colonização microbiana em um animal
US6936258B1 (en) 1999-03-19 2005-08-30 Nabi Biopharmaceuticals Staphylococcus antigen and vaccine
US7115730B1 (en) 1999-04-27 2006-10-03 Chiron Srl Immunogenic detoxified mutant E. coli LT-A-toxin
US7384640B1 (en) 1999-09-30 2008-06-10 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant
HU228264B1 (en) 2000-06-08 2013-02-28 Intercell Ag Immunostimulatory oligodeoxynucleotides
AT410635B (de) 2000-10-18 2003-06-25 Cistem Biotechnologies Gmbh Vakzin-zusammensetzung
CN1977971A (zh) 2001-06-07 2007-06-13 惠氏控股有限公司 作为佐剂的霍乱全毒素的突变体形式
BR0210216A (pt) 2001-06-07 2004-06-08 Wyeth Corp Holotoxina do cólera imunogênica, mutante (ct-crm), composição imunogênica, métodos para aumentar a resposta imune de um hospedeiro vertebrado a um antìgeno, e para produzir uma holotoxina do cólera imunogênica, mutante, sequência ou molécula de ácido nucleico isolado e purificado, célula hospedeira, e, uso de uma holotoxina do cólera mutante
MXPA03011701A (es) 2001-06-15 2004-12-06 Nhibitex Inc Anticuerpos monoclonales y policlonales de reaccion que reconocen las proteinas de superficie a partir de estafilococos coagulasa-negativos y staphylococcus aureus.
GB0118249D0 (en) 2001-07-26 2001-09-19 Chiron Spa Histidine vaccines
NZ561879A (en) 2003-03-07 2009-05-31 Wyeth Corp Polysaccharide - staphylococcal surface adhesin carrier protein conjugates for immunization against nosocomial infections
CA2519511A1 (en) 2003-03-17 2004-09-30 Wyeth Holdings Corporation Mutant cholera holotoxin as an adjuvant and an antigen carrier protein
GB0323103D0 (en) 2003-10-02 2003-11-05 Chiron Srl De-acetylated saccharides
JP2008513406A (ja) 2004-09-22 2008-05-01 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム 免疫原性組成物
GB0606416D0 (en) * 2006-03-30 2006-05-10 Glaxosmithkline Biolog Sa Immunogenic composition
MY148405A (en) * 2006-03-30 2013-04-30 Glaxosmithkline Biolog Sa Immunogenic composition
AR060187A1 (es) * 2006-03-30 2008-05-28 Glaxosmithkline Biolog Sa Composicion inmunogenica
WO2007127668A2 (en) 2006-04-26 2007-11-08 Wyeth Novel processes for coating container means which inhibit precipitation of polysaccharide-protein conjugate formulations
US9132184B2 (en) * 2006-11-07 2015-09-15 Sanofi Pasteur Biologics, Llc Stabilization of vaccines by lyophilization
ES2615390T3 (es) 2008-03-05 2017-06-06 Sanofi Pasteur Proceso para estabilizar una composición de vacuna que contiene adyuvante
JP5395264B2 (ja) * 2009-06-22 2014-01-22 ワイス・エルエルシー 黄色ブドウ球菌（ｓｔａｐｈｙｌｏｃｏｃｃｕｓａｕｒｅｕｓ）抗原の免疫原性組成物

Also Published As

Publication number Publication date
SI3150222T1 (sl) 2020-02-28
MX2013006960A (es) 2013-07-15
PT3150222T (pt) 2020-02-03
ES2769425T3 (es) 2020-06-25
JP6097478B2 (ja) 2017-03-15
DK3150222T3 (da) 2020-01-27
HUE033072T2 (hu) 2017-11-28
DK2654784T3 (en) 2017-02-13
MX350170B (es) 2017-08-28
CN103826656A (zh) 2014-05-28
CN103826656B (zh) 2015-08-26
HK1197370A1 (en) 2015-01-16
HUE047263T2 (hu) 2020-04-28
EP2654784A2 (en) 2013-10-30
EP3150222B1 (en) 2019-11-27
SI2654784T1 (sl) 2017-01-31
IL226793B (en) 2019-02-28
CA2819120A1 (en) 2012-06-28
RU2013128277A (ru) 2015-01-27
BR112013016153A2 (pt) 2017-07-11
RU2570730C2 (ru) 2015-12-10
CA2819120C (en) 2016-07-05
AU2011346535B2 (en) 2015-09-24
EP2654784B1 (en) 2016-12-07
EP3150222A1 (en) 2017-04-05
US20130259896A1 (en) 2013-10-03
WO2012085872A2 (en) 2012-06-28
PL3150222T3 (pl) 2020-05-18
KR20150129071A (ko) 2015-11-18
PT2654784T (pt) 2017-02-13
WO2012085872A3 (en) 2012-08-30
JP2012136518A (ja) 2012-07-19
KR101808398B1 (ko) 2017-12-12
ES2614815T3 (es) 2017-06-02
KR20130114210A (ko) 2013-10-16
AU2011346535A1 (en) 2013-06-13

Similar Documents

Publication Publication Date Title
SG10201406520YA (en) Immunogenic compositions of staphylococcus aureus antigens
IL226793B (en) Stable immunogenic compositions of staphylococcus aureus antigens
ZA202002470B (en) Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof
IL231104A0 (en) Helper assemblies of antigens for Staphylococcus aureus
EP2549993A4 (en) ANTIMICROBIAL COMPOSITIONS
ZA201403788B (en) Stable pesticidal compositions
ZA201300073B (en) Compositions comprising optical benefit agents
AP2013006769A0 (en) Pesticidal compositions
BR112013017664A2 (pt) composições de pó de cacau
GB201015132D0 (en) Vaccine composition
IL238328A0 (en) Stable preparations that include peracetic acid
PL2768936T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
EP2531026A4 (en) ANTIMICROBIAL FORMULATIONS ON POLYSACCHARID BASE
EP2640418A4 (en) IMMUNOGENIC COMPOSITIONS
EP2605654A4 (en) ANTIMICROBIAL COMPOSITIONS
PL2407155T3 (pl) Formulacje inekalcytolu
ZA201301908B (en) Immunogenic compositions
GB201010944D0 (en) Antimicrobial compositions
GB201002594D0 (en) Antimicrobial compositions
GB201111128D0 (en) Antimicrobial compositions
GB201003799D0 (en) Antimicrobial compositions
GB201013150D0 (en) Antimicrobial compositions
AU2012900227A0 (en) Compositions of nimorazole
GB201005587D0 (en) Novel formulations